|
Qb Test- a new way of diagnosing and monitoring Adult ADHD For a long time ADHD was considered to be rather rare condition only effecting children and adolescents. However during the last decade, attention-deficit/hyperactivity disorder (ADHD) has been largely reconceptualised as a lifespan disorder and not merely a condition of childhood. ADHD is characterized by deficits in sustained attention or persistence, resistance to distraction, voluntary motor inhibition, and the regulation of activity level relative to same-aged peers (American Psychiatric Association, 2001). Originating in early childhood, ADHD is a relatively persistent condition. There are a difference of opinions to what extent the condition persists into adulthood however it has been stated that 80% of diagnosed children continuing to meet diagnostic criteria in adolescence and up to 67% continuing to have clinically significant symptoms of the disorder into adulthood (Barkley et al., 2002). Other authors would suggest lower figures. Assessing whether an adult has ADHD can be difficult considering the high co-morbidity of anxiety, dysphoria and depression (Lomas & Gartside, 1999; Murphy & Barkley, 1999; Riordan, Flashman et al., 1999). Behavioral manifestations of inattention and hyperactivity such as disorganization, restlessness, and distractibility are normal human characteristics that are also symptoms of many conditions commonly co morbid with ADHD (Murphy & Adler, 2003). Most commonly, these symptoms are assessed using highly subjective behavioral rating scales. The NICE guidelines (guidance.nice.org.uk/CG72) are extensive but in essence recommend that the diagnosis be made on the basis of a thorough clinical interview including objective developmental information when possible. There is in principal no difference in the diagnosis of children/adolescents or adults and the treatment is in principal the same (a combination of pharmacotherapy, psychotherapy (CBT) and psychosocial support). All these elements of treatment are already available through the Angloeuropeanclinic. We are pleased to announce that from the beginning of April the Angloeuropeanclinic will be able to provide QbTest to our patients who have suspected or diagnosed ADHD. QbTest is widely used in Europe and is being used in a growing number of UK centres. It is an objective tool that measures all three core signs of ADHD – inattention, impulsivity and hyperactivity in patients between 6 and 55 years of age. |
For those who might have ADHD What is QbTest? QbTest is a computer-based test that combines a test of attention ability with a movement analysis based on an infrared measurement system. Test results are assembled into a report and compared with norm data from other people of the same sex and age. This way the tester can see how you react when you concentrate on a task in comparison with people who do not have ADHD. Why should I take a QbTest? The result of QbTest can provide valuable information to investigate: How does the test work? The test is done in front of a computer screen. The test equipment consists of an infrared camera, a camera marker and a response button. During the test a number of symbols are shown at regular intervals on the computer screen. Your task is to push the responder button when the same symbol is repeated. Where can I have the test? Initially the test will only be available at our clinic in Southend on Sea. The test is only available as a part of a full clinical assessment. In the future the test is likely to be available at our other consultation sites (Suite 4, 7 Harley Street and Priory Hospital Chelmsford) What is the cost of the test? Usually you will have two tests (before and after treatment). These are charged at a cost of £125 each. If there is a need for further tests (as a part of medication monitoring) these will be charged at a cost of £75. Will the test be covered by my insurance provider? This depends on your insurance cover. |
Links |